# The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

> **NCT00830401** · PHASE2 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 700 (actual)

## Conditions studied

- Minor Intra-uterine Abnormalities

## Interventions

- **PROCEDURE:** Treatment of predefined abnormality by hysteroscopic surgery
- **DRUG:** Ofloxacinum/Doxycycline

## Key facts

- **NCT ID:** NCT00830401
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2008-11
- **Final completion:** 2009-03
- **Target enrollment:** 700 (ACTUAL)
- **Why stopped:** Abnormality prevalence revealed to be much lower than expected.
- **Last updated:** 2015-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830401, "The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00830401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*